Track the 제노레이 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 제노레이 has recorded 40 public disclosures. Market capitalisation: €42.3bn. The latest transaction was reported on 27 May 2026 (Other). Among the most active insiders: 박병욱. All data is free.
38
Insider Decl.
n/a
Thresholds
€10,111
28 ops.
Buy Volume
€45,054
2 ops.
Sell Volume
20Σ signal
Buys €10,111€45,054 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,875 of 29,156 companies
49.5
score / 100
Value
62
Quality
37
FCF yld9.1%
Earn yld1.8%
EV/EBITDA9.0x
ROE3.2%
Gross mgn39%
Net mgn0.7%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Genorey is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.